Premium
Treatment outcomes in a cohort of P alestine refugees with diabetes mellitus followed through use of E ‐ H ealth over 3 years in J ordan
Author(s) -
Khader Ali,
Ballout Ghada,
Shahin Yousef,
Hababeh Majed,
Farajallah Loai,
Zeidan Wafaa,
AbuZayed Ishtaiwi,
Kochi Arata,
Harries Anthony D.,
Zachariah Rony,
Kapur Anil,
Shaikh Irshad,
Seita Akihiro
Publication year - 2014
Publication title -
tropical medicine and international health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.056
H-Index - 114
eISSN - 1365-3156
pISSN - 1360-2276
DOI - 10.1111/tmi.12241
Subject(s) - medicine , cohort , diabetes mellitus , cohort study , obesity , retrospective cohort study , endocrinology
Objective The aim of this study was to use E‐Health to report on 12‐month, 24‐month and 36‐month outcomes and late‐stage complications of a cohort of Palestine refugees with diabetes mellitus ( DM ) registered in the second quarter of 2010 in a primary healthcare clinic in Amman, Jordan. Method Retrospective cohort study with treatment outcomes censored at 12‐month time points using E‐Health in UNRWA's Nuzha Primary Health Care Clinic. Results Of 119 newly registered DM patients, 61% were female, 90% were aged ≥40 years, 92% had type 2 DM with 73% of those having hypertension and one‐third of patients were newly diagnosed. In the first 3 years of follow‐up, the proportion of clinic attendees decreased from 72% to 64% and then to 61%; the proportion lost to‐follow‐up increased from 9% to 19% and then to 29%. At the three time points of follow‐up, 71–78% had blood glucose ≤180 mg/dl; 63–74% had cholesterol <200 mg/dl; and about 90% had blood pressure <140/90 mmHg. Obesity remained constant at 50%. The proportion of patients with late‐stage complications increased from 1% at baseline to 7% at 1 year, 14% at 2 years and 15% at 3 years. Conclusion Nuzha PHC Clinic was able to monitor a cohort of DM patients for 3 years using E‐Health and the principles of cohort analysis. This further endorses the use of cohort analysis for managing patients with DM and other non‐communicable diseases.